The scope of this focused update is limited to addressing recommendations on duration of
dual antiplatelet therapy (DAPT)(aspirin plus a P2Y12 inhibitor) in patients with coronary …

Saphenous vein grafts (SVGs) remain the most frequently used conduits in coronary artery
bypass graft surgery (CABG). Despite advances in surgical techniques and …

The recommendations listed in this document are, whenever possible, evidence based.
Writing group members performed these relevant supplemental literature searches with key …

Objective: To review our current understanding of the epidemiology and pathogenesis of
vein graft failure (VGF), give an overview of current preventive and interventional measures …

The Japanese Circulation Society (JCS) published the “Guidelines for elective percutaneous
coronary intervention [PCI] in patients with stable coronary disease” in 2000. In 2006 …

Objective To assess differences in estimated treatment effects for mortality between
observational studies with routinely collected health data (RCD; that are published before …

BACKGROUND: Graft patency is the postulated mechanism for the benefits of coronary
artery bypass grafting (CABG). However, systematic graft imaging assessment after CABG is …

Multiple guidelines and consensus papers have addressed the role of antithrombotic
strategies in patients with established coronary artery disease (CAD). Since evidence and …

Surgical treatment for angina pectoris was first proposed in 1899. Decades of experimental
surgery for coronary artery disease finally led to the introduction of coronary artery bypass …

Background Anti‐platelet therapy is an important component of medical therapy post
coronary artery bypass grafting (CABG). While aspirin administration is a Class I indication …